Modified Protection against Toxoplasma gondii Lethal Infection and Brain Cyst Formation by Vaccination with SAG2 and SRS1

Journal of Veterinary Medical Science

Volumn 63, Issue 4, 2001, Pages 433-438

  Mishima, Masayuki ^a   Xuan, Xuenan ^a   Shioda, Akifumi ^b   Omata, Yoshitaka ^a   Fujisaki, Kozo ^a   Nagasawa, Hideyuki ^a   Mikami, Takeshi ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

P54; SAG2; SRS1; Toxoplasma gondii; Vaccination

Indexed keywords

TOXOPLASMA GONDII;

MEMBRANE ANTIGEN; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PROTOZOAL VACCINE; PROTOZOON ANTIBODY; RECOMBINANT VACCINE; SRS1 PROTEIN, TOXOPLASMA GONDII; SURFACE ANTIGEN P22, TOXOPLASMA;

ANIMAL; ANIMAL DISEASE; ANIMAL PARASITOSIS; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; MOUSE; NONPARAMETRIC TEST; PARASITOLOGY; STANDARD; TOXOPLASMA; TOXOPLASMOSIS; VACCINATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; SEQUENCE ANALYSIS, DNA; SPECIFIC PATHOGEN-FREE ORGANISMS; STATISTICS, NONPARAMETRIC; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TOXOPLASMOSIS, CEREBRAL; VACCINATION; VACCINES, SYNTHETIC;

EID: 0035321583     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.63.433     Document Type: Article

References (31)

1. Baril, L., Ancelle, T., Goulet, V., Thulliez, P., Tirard-Fleury, V. and Carme, B. 1999. Riskfactors for Toxoplasma infection in pregnancy: a case-control study in France. Scand. J. Infect. Dis. 31: 305-309.
2. Buffolano, W., Gilbert, R.E., Holland, F.J., Fratta, D., Paulumbo, F. and Ades, A.E. 1996. Risk factors for recent Toxoplasma infection in pregnant women in Naples. Epidemiol. Infect. 116:347-351.
3. Burg, J. L., Perelman, D., Kasper, L.H., Ware, P.L. and Boothroyd, J.C. 1988. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J. Immunol. 141: 584-3591.
4. Cesbron-Derauw, M.F., Tomabo, S., Beauchamps, P., Fourmax, M P., Camus, D., Capron, A. and Dubremetz, J.F. 1994. Similarities between the primary structures of two distinct major surface proteins of Toxoplasma gondii. J. Biol. Chem. 269: 16217-16222.
5. Channon, J Y., Suh, E.I., Seguin, R.M. and Kasper L.H. 1999. Attachment ligands of viable Toxoplasma gondii induce solbul immunosupressive factors in human monocytes. Infect. Immun. 67: 2547-2551.
6. Chen, X.G., Ma, X., Wu, K., Peng, H.J., Shen, S.M., Liu, G.Z. and Chan, S.M. 1998. Expression of P30, the major surface antigen of Toxoplasma gondii in Baculovirus-insect system and the evaluation of immune response induced by P30. J. Protozool. Res. 8: 19-27.
7. Chuang, Y.H., Chiang, B.L., Chou, C.C and Hsieh, K.H. 1997. Immune effector cells induced by complete Freund's adjuvant exert an inhibitory effect on antigen-specific type 2 T helper responses. Clin. Exp. Allergy 27: 315-324.
8. Dubey, J.P., Baker, D. G, Davis, S.W and Urban, J .F. Jr. 1994. Persistence of immunity to toxoplasmosis in pigs vaccinated with a nonpersistent strain of Toxoplasma gondii. Am. J. Vet. Res. 55: 982-987.
9. Grimwood, J. and Smith, J.E. 1996. Toxoplasma gondii: the role of parasite surface and secreted proteins in host cell invasion Int. J. Parasitol. 26: 169-173.
10. Hehl, A., Krieger, T. and Boothyloid, J.C. 1997. Identification and characterization of SRS1, a Toxoplasma gondii surface antigen upstream of and related to SAG1. Mol. Biochem. Parasitol. 89:271-282.
11. + T cell immunity against fatal Toxoplasma gondii infection in mice. J. Immunol. 147: 3501-3506.
12. Kapperud, G., Jenum, P.A., Stray-Pedersen, B., Melby, K.K., Eskild, A. and Eng, J. 1996. Risk factors for Toxoplasma gondii infection in pregnancy results of a prospective case-control study in Norway. Am. J. Epidemiol. 144: 405-412.
13. Letscher-Bru, V, Villard, O., Risse, B., Zauke, M., Klein, J. and Kien, T. 1998. Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice. Infect. Immun. 66: 4503-4506.
14. Lindsay, D.S., Blagburn, B.L. and Dubey, J.P. 1993. Safety and results of challenge of weaned pigs given a temperature-sensitive mutant of Toxoplasma gondii. J. Parasitol. 79: 71-76.
15. Lynch, N.J., Obendorf, D L., Statham, P. and Reddacliff, G.L. 1993. An evaluation of a live Toxoplasma gondii vaccine in Tammar wallabies (Macropus eugenii). Aust. Vet. J. 70: 352-353.
16. Mineo, J.R. and Kasper, L.H. 1994. Attachment of Toxoplasma gondii to host cells involves major surface protein, SAG1 (P30). Exp. Parasitol. 79: 11-24.
17. Nagasawa, H. and Himeno, K. 1995. Experimental infection, pp. 312-323. In: Basic Techniques for Immunology (Takatsu, K. and Taki, S. eds.), Yodosha, Tokyo (in Japanese).
18. Nguyen, T.D., Bigaignon, G., Van Broeck, J., Vercammen, M., Nguyen, T.N., Delmee, M., Turneer, M., Wolf, S.F. and Coutelier, J.P, 1998. Acute and chronic phase of Toxoplasma gondii infection in mice modulate the host immune responses. Infect. Immun. 66: 2991-2995
19. Nielsen, H.V., Lauemoller, S.L., Christiansen, L., Buus, S., Fomsgaard, A. and Petersen, E. 1999. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 Gene. Infect. Immun. 67: 6358-6363.
20. Petersen, E., Nielsen, H. V., Christiansen, L. and Spenter, J. 1998. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii. Vaccine 16: 1283-1289.
21. Pinckney, R.D., Lindsay, D.S., Blagburn, B.L., Boosinger, T.R., McLaughlm, S.A. and Dubey, J.P. 1994. Evaluation of the safety and efficacy of vaccination of nursing pigs with living tachyzoites of two strains of Toxoplasma gondii. J. Parasitol. 80: 438-448.
22. Prince, J.B., Auer, K.L., Huskinson, J., Parmley, S.F., Araujo, F.G. and Remington, J.S. 1990. Cloning, expression, and cDNA sequence of surface antigen P22 from Toxoplasma gondii. Mol. Biochem. Parasitol. 43: 97-106.
23. Saavedra, R., Meuter, F., Decourt, J. and Herion, P. 1991. Human T cell clone identifies a potentially protective 54-kDa protein antigen of Toxoplasma gondii cloned and expressed in Eschericha coli. J. Immunol. 147: 1975-1982.
24. Saito, A., Sakurai, H., Terada, S., Igarashi, I., Suzuki, N., Osaki, H., Kudo, H., Sakata, Y., Okamoto, K. and Yoshida, H. 1989. Inhibitory effect of Toxoplasma lysate antigen on the multiplication of transplanted tumor in mice. Zentralbl. Bacterial. Hyg. 271: 114-126.
25. Seng, S., Nagasawa, H., Maki, Y., Yokoyama, M., Inoue, N., Xuan, X., Igarashi, I., Saito, A., Fujisaki, K., Mikami, T., Suzuki, N. and Toyoda, Y. 1999. Increased susceptibility to Toxoplasma gondii infarction in SAG-1 transgenic mice. Int. J. Parasitol. 29: 1433-1436.
26. Seng, S , Yokoyama, M., Suzuki, R., Maki, Y., Kato M., Lim, C., Zayatiin, B., Inoue, N., Xuan, X., Igarashi, I., Nagasawa, H., Fujisaki, K., Mikami, T., Suzuki, N. and Toyoda, Y. 2000. Expression of SAG1 of Toxoplasma gondii in Transgenic mice. Parasitol. Res. (in press)
27. Valkoum, A. 1983. Continual cultivation of Toxoplasma gondii on HeLa cells. Folia Parasitol. 30: 289-294.
28. Warnekulasuriya, M. R., Johnson, J. D. and Holliman, R. E. 1998. Detection of Toxoplasma gondii in cured meats. Int. J. Food Microbiol. 45: 211-215.
29. Wilkins, M.F., O'Connell, E. and Te Punga, W. A. 1988. Toxoplasmosis in sheep III. Further evaluation of the ability of a live Toxoplasma gondii vaccine to prevent lamb losses and reduce congenital infection following experimental oral challenge. N.Z. Vet. J. 36: 86-89.
30. Wilkins, M.F. and O'Connell, E. 1992. Vaccination of sheep against Toxoplasma abortion. Surveillance 19: 20-23.
31. Yap, G.S., Scharton-Kersten, T., Ferguson, D.J.P., Howe, D., Suzuki, Y. and Sher, A. 1998. Partially protective vaccination permits the development of latency in a normally virulent strain of Toxoplasma gondii. Infect. Immun. 66: 4382-4388.